4.6 Article

Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat

Related references

Note: Only part of the references are listed.
Article Neurosciences

Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

Joyce S. Balami et al.

CNS & Neurological Disorders-Drug Targets (2013)

Article Endocrinology & Metabolism

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats

Simon Nagel et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)

Review Neurosciences

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia

Brad A. Sutherland et al.

JOURNAL OF PHYSIOLOGY-LONDON (2011)

Review Endocrinology & Metabolism

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity

George W. J. Harston et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)

Article Endocrinology & Metabolism

Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain

Toru Yamashita et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)

Article Biochemical Research Methods

TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion

Fudong Liu et al.

JOURNAL OF NEUROSCIENCE METHODS (2009)

Article Clinical Neurology

Thrombolytic toxicity: Blood brain barrier disruption in human ischemic stroke

Chelsea S. Kidwell et al.

CEREBROVASCULAR DISEASES (2008)

Article Multidisciplinary Sciences

Key role of tissue plasminogen activator in neurovascular coupling

Laibaik Park et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Endocrinology & Metabolism

The neurotoxicity of tissue plasminogen activator?

J Kaur et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)